ALT earnings: real EPS beat/miss history, analyst consensus Buy, P/E -3.02. Updated 2026-07-23.
Altimmune (ALT) Research Hub
Altimmune (ALT) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 3.27 USD (-2.39%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -3.02, market cap 0.24B. This hub links to the full technical, earnings and options research available for ALT.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 3.27 USD (-2.39%) |
| 52-week range | 2.58 USD – 3.55 USD |
| Trend regime | Range |
| 14-day RSI | 58.4 (Bullish) |
| Trailing P/E | -3.02 |
| Market cap | 0.24B |
| Dividend yield | 0.00% |
Available research for ALT
Covered Call on ALT: how it works, illustrative setup around the real 3.27 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on ALT: how it works, illustrative setup around the real 3.27 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on ALT: how it works, illustrative setup around the real 3.27 USD price, max profit/loss, breakeven and when to use it. Educational.
ALT technical analysis: range, last 3.27 USD, RSI 58.4, 52w range 2.58 USD–3.55 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is ALT in?
Altimmune (ALT) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is ALT in an uptrend or downtrend?
As of 2026-09-11, ALT is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is ALT's trailing P/E ratio?
ALT's trailing P/E is -3.02, with a market cap of 0.24B. See the earnings research page for full valuation detail.